The Wall Street Journal: Nonprofit buys back rights to tuberculosis drug after sharp price hike

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 22 September, 2015 by The TZ Newswire Staff

The Wall Street Journal: Nonprofit buys back rights to tuberculosis drug after sharp price hike

An Indiana not-for-profit buys back the rights to a tuberculosis drug it sold to a small drug company just three weeks ago, amid outcry after a hefty price increase by the company.
read more

See also
- Next Article Craig Venter’s company in deal for whole exome tests at new low cost
- Previous Article How to beat activist investors at their own game
Editorial Calender

September 2015

M T W T F S S

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30

« Aug Oct »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 22 September, 2015 by The TZ Newswire Staff

The Wall Street Journal: Nonprofit buys back rights to tuberculosis drug after sharp price hike

See also

Editorial Calender

Recent Tags